Pearson


COVID-19 hurting Pearson's Global Assessment division

23/03/20 -"Our target price moves from 596p to 455p after we adjusted our forecasts in the aftermath of this morning's profit warning related to COVID-19 (please refer to our 23 March 2020 Latest). The ..."

Pages
58
Language
English
Published on
23/03/20
You may also be interested by these reports :
30/10/25
WPP reported broad-based declines in Q3 2025, with organic revenue down across all major markets and most sectors, except India and healthcare. Net ...

28/10/25
M6 published relatively good Q3 25 results that came above our expectations, which were pessimistic given the current French political context. The ...

23/10/25
RELX released 9M figures in line with our expectations, confirming (for now) our theory that RELX is a winner of the GenAI technology. Moreover, ...

22/10/25
Definitely, investors struggle to make up their minds on Wolters Kluwer’s (BUY; Netherlands) status when it comes to Gen AI technology. Since our ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO